Skip to content
Patentative

How a 2018 continuation led to Masimo’s $634M verdict against Apple

Updated Oct 23, 2026

Short answer

Masimo filed US 10,433,776 on Oct 29, 2018 as a continuation in a family that began with a 2001 provisional and a 2002 nonprovisional. It issued 344 days later. On Nov 14, 2025 a jury found for Masimo on claims 11–14 and awarded $634,313,913. With prejudgment interest the total is about $818M, per press reports. Appeals are pending.

As of Oct 23, 2026; re-check the docket. Sources: the patent (USPTO), Bloomberg Law, iPhone in Canada.

What is the continuation chain behind the ’776 patent?

The ’776 patent is the sixth nonprovisional in a straight line of continuations. Each one was filed as a continuation of the one before. Under 35 U.S.C. 120, that requires the parent to still be pending when the child is filed. So at least one application in the family stayed pending from June 2002 to October 2018, a little over 16 years.

Every date below is printed on the face of the patent (USPTO full text), except the court events, which come from press reports.

The ’776 family, oldest first

  1. Provisional filed

    60/302,564

    Earliest priority date. A provisional does not set the earliest benefit date for the continuing application fee.

  2. First nonprovisional filed

    10/184,028 → US 6,697,658

    Claims the provisional. This is the earliest benefit date for every later continuation.

  3. Continuation filed

    10/785,573 → US 7,295,866

  4. Continuation filed

    11/939,519 → US 8,457,703

  5. Continuation filed

    13/908,957 → US 9,848,806

  6. Continuation filed

    15/820,082

    The direct parent of the ’776 application. We did not check its later status.

  7. Continuation filed(the ’776 patent)

    16/174,144

    Published Mar 7, 2019 as US 2019/0069814 A1.

  8. Patent issued(the ’776 patent)

    US 10,433,776 B2

    344 days after filing. 16 claims, 0 days of patent term adjustment, subject to a terminal disclaimer.

  9. Certificate of correction

    Corrects two words in the specification and one phrase in claim 11.

  10. Inter partes review certificate

    IPR2020-01524

    Claims 1–16 found patentable.

  11. Jury verdict

    For Masimo on claims 11–14; $634,313,913 (press reports).

  12. Final judgment

    Verdict kept; claims 11–14 held not invalid; no willfulness (press reports).

  13. Prejudgment interest awarded

    About $184M, for a total of about $818M (press reports). Appeals pending.

What did the court decide, and where does the case stand?

The case is Masimo Corp. v. Apple Inc., No. 8:20-cv-00048-JVS (C.D. Cal.). On Nov 14, 2025 the jury found for Masimo on claims 11–14 of the ’776 patent and awarded $634,313,913. Press reports describe the features at issue as Apple Watch’s workout mode and heart-rate notifications (AppleInsider).

Claim 11 recites a patient monitor whose processors calculate pulse rate while switching, on a trigger signal, between two light-source control protocols with different duty cycles and power consumption. Claims 12–14 depend from it.

On July 20, 2026, Judge Selna entered final judgment. Per Bloomberg Law and Strata-gee, he kept the verdict, found claims 11–14 not invalid, and found no willfulness. Masimo filed a notice of appeal the same day. On Oct 5, 2026 the court awarded prejudgment interest. Press reports put it at about $184M, for a total of about $818M (iPhone in Canada). Apple has said it will appeal. We could not confirm a Federal Circuit docket number.

Status check

As of Oct 23, 2026; re-check the docket. The post-trial figures above come from press reports, not the court’s own orders. The separate trade-secret claims in the same case are not covered here.

What can practitioners learn from the ’776 family?

Keeping a family pending kept options open

By 2018 the earliest application was more than 16 years old. Because a continuation was always on file, new claims could still be presented on the 2002 disclosure. Once the last pending member issues or is abandoned, that door closes for good.

Claims aimed at a known product are proper

The sources we checked do not say what products Masimo’s counsel had in mind when the 2018 claims were drafted, and we draw no conclusion about it. The law on the point is settled. Kingsdown (Fed. Cir. 1988) says:

“[N]or is it in any manner improper to amend or insert claims intended to cover a competitor’s product the applicant’s attorney has learned about during the prosecution of a patent application.”

The limit is support. It is not improper to broaden claims to encompass a competitor’s products “as long as the disclosure supports the broadened claims” (Liebel-Flarsheim, 2004, quoted in Google v. Sonos, 2025).

Support had to come from the 2002 disclosure

A continuation gets the earlier filing date only for claims the earlier disclosure supports (35 U.S.C. 120). New claims in 2018 had to find written-description support in a specification carried forward from 2002. The courts watch this closely: the requirement is “particularly important” when claims are added later in response to others’ developments (Quake v. Lo, 2019).

On the record we checked, the claims held up. The PTAB found claims 1–16 patentable in IPR2020-01524 (certificate issued May 9, 2024). An IPR can only raise novelty and obviousness over patents and printed publications (35 U.S.C. 311(b)), so it did not test written description. The district court found claims 11–14 not invalid, per press reports.

From filing to grant in 344 days

The application was filed on Oct 29, 2018, published on Mar 7, 2019, and issued on Oct 8, 2019. The face of the patent does not say how examination was expedited, if at all, and we did not review the file history. The general point stands: a pending application has no enforceable claims, so time to grant matters. For a fast route, see Track One for continuations.

What would the same filing owe today?

The continuing application fee took effect on Jan 19, 2025 (89 FR 91898). Benefit claims presented before then never owe it (CAF Guide Q6), so the real 2018 filing paid nothing. Here is what an identical continuation would owe if filed now.

The fee runs from the earliest benefit date, not the priority date. A provisional does not count (CAF Guide Q4). For this family the earliest benefit date is June 26, 2002, the filing date of 10/184,028, not July 2, 2001.

Continuing application fee for a continuation in the ’776 family, earliest benefit date Jun 26, 2002. Our calculation under 37 CFR 1.17(w).
Filing dateLargeSmallMicro
On or before Jun 26, 2008$0$0$0
Jun 27, 2008 to Jun 27, 2011$2,700$1,080$540
From Jun 28, 2011, including today$4,000$1,600$800
  • The 9-year anniversary, June 26, 2011, was a Sunday. Filing on the next business day, June 27, still owed only the 6-year amount (CAF Guide Q14–15).
  • The patent does not state Masimo’s entity size, so all three rates are shown. The fee is on top of the basic filing, search and examination fees.
  • If the fee is not paid, the benefit claim is not entered and the application loses the earlier date.

Informational only, not legal advice. Have a registered patent practitioner review before filing.

Questions about the Masimo continuation

Was the Masimo patent in the Apple case a continuation?

Yes. US 10,433,776 issued from application 16/174,144, filed Oct 29, 2018 as a continuation of 15/820,082. The chain runs back through four earlier continuations to application 10/184,028, filed June 26, 2002, which claims a provisional filed July 2, 2001. Source: the face of the patent.

What is the priority date of the ’776 patent?

Its earliest claimed priority is provisional 60/302,564, filed July 2, 2001. Its earliest benefit date, the date used for the 20-year term and for the continuing application fee, is June 26, 2002, when the first nonprovisional was filed. Google Patents lists an anticipated expiration of June 26, 2022.

How much was the Masimo v. Apple verdict, and what is the total now?

On Nov 14, 2025 a jury in Masimo Corp. v. Apple Inc., No. 8:20-cv-00048-JVS (C.D. Cal.), found for Masimo on claims 11–14 and awarded $634,313,913. Final judgment was entered July 20, 2026. Press reports say prejudgment interest awarded on Oct 5, 2026 adds about $184M, for about $818M in total. Masimo has appealed and Apple has said it will appeal. This is as of Oct 23, 2026; re-check the docket.

Is it proper to write continuation claims with a competitor’s product in mind?

Yes, if the specification supports the claims. Kingsdown Medical Consultants v. Hollister (Fed. Cir. 1988) says there is nothing improper in amending or inserting claims intended to cover a competitor’s product the applicant’s attorney has learned about during prosecution. We do not know what products Masimo’s counsel had in mind in 2018, and the sources we checked do not say.

What continuing application fee would the same filing owe today?

By our calculation, $4,000 for a large entity ($1,600 small, $800 micro). The earliest benefit date is June 26, 2002, so a continuation filed today is more than 9 years past it. The fee took effect Jan 19, 2025, so the actual 2018 filing paid none.

Is one of your families still pending?

Send the application number and a link to a competitor’s product. We check whether the pending specification may support claims covering it, map the support to paragraphs, and flag the last day to file. Reply by email within 48 hours. The first reviews are free.